Diabetes Mellitus (Lecture 2). Type 2 DM 90% of diabetics (in USA) Develops gradually may be without obvious symptoms may be detected by routine screening.

Slides:



Advertisements
Similar presentations
TIME TO ACT Type 2 diabetes, the metabolic syndrome and cardiovascular disease in Europe CONTENTS Section One: Background to type 2 diabetes, the metabolic.
Advertisements

Long-term Complications of Type 2 Diabetes
Blood glucose levels and Vascular Disease. Chronic elevation of blood glucose levels leads to the endothelium cells taking in more glucose than normal.
Type 2 Diabetes Mellitus Aetiology, Pathogenesis, History, and Treatment.
Diabetes Mellitus.
Lecture 26 Non-insulin dependent diabetes mellitus (NIDDM) Maturity onset diabetes Type 2 diabetes.
Diabetes and Aging MCB 135K Laura Epstein 4/14/06.
Hormonal control of circulating nutrients Overview: The need for glucose and nutrient homeostasis Interchange of nutrients / fuel stores Insulin:secretion.
Pancreatic Hormones Glucagon Insulin.
Diabetes. Diabetes Mellitus Disease in which the body doesn’t produce or properly use insulin, leading to hyperglycemia.
Control of blood sugar levels By: Jake Baird and Nick Mulligan.
What is Diabetes?.
What you do this lesson Copy all notes that appear in blue or green Red / White notes are for information and similar notes will be found in your monograph.
Diabetes mellitus.
Metabolic effects of Insulin and Glucagon Metabolism in the Well fed state Metabolism in the Starvation and Diabetes Mellitus Integration of Metabolism.
Endocrine Block | 1 Lecture | Dr. Usman Ghani
Adult Medical-Surgical Nursing
Diabetes Mellitus Diabetes Mellitus is a group of metabolic diseases characterized by elevated levels of glucose in blood (hyperglycemia) Diabetes Mellitus.
Biochemical Aspects of Diabetes Mellitus
CMT Training The Center for Life Enrichment Resource: MTTP Student Manual.
Chapter 24 Chapter 24 Exercise Management.  Diabetes is a chronic metabolic disease characterized by an absolute or relative deficiency of insulin that.
DIABETES AND HYPOGLYCEMIA. What is Diabetes Mellitus? “STARVATION IN A SEA OF PLENTY”
By Hussam A.S. Murad and Khaled A. Mahmoud Department of Pharmacology and Therapeutics Faculty of Medicine, Ain Shams University By Hussam A.S. Murad.
WHY REGULATE PLASMA GLUCOSE? Set Point: mg/100 ml plasma Glucose is virtually the only fuel the brain can use to make ATP (also ketones) If plasma.
DIABETES MELLITUS By Prarit Arora
Reem Sallam, MD, MSc. PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Dr. Amr S. Moustafa, MD, PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Regulating Blood Sugar Islets of Langerhans groups of cells in the pancreas beta cells produce insulin alpha cells produce glucagon.
Regulation of insulin levels Starter: what do each of the following cells produce and are they part of the endocrine or exocrine system; –α cells –β cells.
Diabetes mellitus (DM), also known simply as diabetes, is a group of metabolic diseases in which there are high blood sugar levels over a prolonged period.
Hormonal regulation of glycaemia Alice Skoumalová.
Endocrine Block Glucose Homeostasis Dr. Usman Ghani.
content sugar glucose Sources Absorption Diabetes Metabolism OF Carbohydrate The control of blood sugar Insulin Diagnosis of Diabetes Sugar level in the.
Pancreas Pancreas is a glandular organ located beneath the stomach in the abdominal cavity. Connected to the small intestine at the duodenum. Functions.
Chronic elevation of blood glucose levels leads to the endothelium cells taking in more glucose than normal damaging the blood vessels. 2 types of damage.
Glucose Homeostasis By Dr. Sumbul Fatma.
Overview of Carbohydrate Metabolism: The importance of regulating blood glucose levels.
Endocrine Physiology The Endocrine Pancreas. A triangular gland, which has both exocrine and endocrine cells, located behind the stomach Strategic location.
The Endocrine Pancreas
Biochemical Aspects of Diabetes Mellitus
Dr. Nathasha Luke.  Define the term glucose homeostasis  Describe how blood glucose levels are maintained in the fasting state and fed state  Describe.
Diabetes Mellitus Type 2
LABORATORY DIAGNOSTICS OF DIABETES MELLITUS. Epidemiology About 2 to 4 % of the world population is affected with DM The disease is more common: - in.
Diabetes Mellitus Ch 13 ~ Endocrine System Med Term.
Dixie L. Thompson chapter 20 Exercise and Diabetes.
Oral Diabetes Medications Carol Cordy, MD. Goals Understand how type 2 diabetes affects many organs and how this changes over the course of the illness.
Endocrine System KNH 411. Diabetes Mellitus 7% of population; 1/3 undiagnosed $132 billion in health care Sixth leading cause of death Complications of.
"We can be very successful at controlling diabetes."
Chapter Exercise and Diabetes Dixie L. Thompson C H A P T E R.
Diabetes mellitus.
Diabetes. Objectives: Diabetes Mellitus (DM) Discuss the prevalence of diabetes in the U.S. Contrast the main types of diabetes. Describe the classic.
DM- ANSWERS TO CASES 1&2. ANSWERS 1. How did the insulin deficiency lead to an increase in plasma glucose & ketone conc.? Insulin is responsible for shifting.
 Insulin is a peptide hormone released by beta cells when glucose concentrations exceed normal levels (70–110 mg/dL).  The effects of insulin on its.
What is Diabetes? Definition: A disorder of metabolism where the pancreas produces little or no insulin or the cells do not respond to the insulin produced.
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS.
Diabetes Mellitus ENDO 412. Overview DM is a heterogeneous group of syndromes characterized by an elevation of fasting blood glucose caused by absolute.
DIABETES MELLITUS. Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. DM is associated.
Diabetes mellitus.
Integration of Metabolism
DIABETES MELLITUS DR HEYAM AWAD FRCPATH.
Metabolic Changes in Diabetes Mellitus
Diabetes Mellitus Nursing Management.
Metabolic Changes in Diabetes Mellitus
Metabolic Changes in Diabetes Mellitus
Regulating Blood Sugar
Diabetes Mellitus.
NUTRITION AND FITNESS LIFESYTLE CHANGE PROGRAM
Diabetes Mellitus Passant Mohammed Faculty of science Biochemistry.
Hormonal Regulation of Carbohydrates
Presentation transcript:

Diabetes Mellitus (Lecture 2)

Type 2 DM 90% of diabetics (in USA) Develops gradually may be without obvious symptoms may be detected by routine screening tests BUT: many type 2 diabetics have symptoms of polyuria & polydepsia Polyphagia is less common In type 2 DM: a combination of insulin resistance & dysfunctional  -cells Metabolic changes in type 2: are milder than type 1 as insulin secretion restrain ketoacidiosis (although not adequate) Diagnosis: blood glucose concentration equal or more than 126 mg/dl Treatment : no requirement for insulin to sustain life BUT: insulin may be required to control hypoglycemia in some

Insulin resistance is the decreased ability of target tissues, such as liver, adipose tissue & muscle to respond properly to normal circulating insulin Examples of metabolic effects of insulin resistance: - increased gluconeogenesis (liver synthesis of glucose) - decreased glucose uptake by muscles & adipose tissues

Causes of insulin resistance Insulin resistance increases with weight gain & diminishes with weight loss So, fat accumulation (OBESITY) causes insulin resistance as: - substances produced by fat cells as leptin and resistin may contribute to development of insulin resistance - Free fatty acids elevated in obesity is involved in insulin resistance

Insulin resistance & obesity Obesity is the most common cause of insulin resistance However, most people with obesity & insulin resistance do not develop DM ?? in the absence of defect in  -cell function, nondiabetic, obese individuals can compensate for insulin resistance by: increasing levels of secretion of insulin from  -cells So, glucose levels in blood remain within normal range

Insulin resistance & type 2 DM Insulin resistance alone will not lead to type 2 DM. BUT: type 2 DM will develop in individuals with: insulin resistance + impaired  -cells function This is common to occur in: - elderly - obese - physically inactive - 3-5% of pregnant women (develop gestational DM) All these are unable to sufficiently compensate by increasing insulin release

Dysfunctional  -cells In type 2 DM Initially (In early stages) the pancreas retains  -cell capacity insulin is secreted (may be higher than normal) normal blood glucose levels ________________________________________________ With time (late stages)  -cells become dysfunctional (fat cells substances, FFA & hyperglycemia)  -cells fail to secrete enough insulin Increased blood glucose levels (hyperglycemia)

Progression of type 2 DM

Metabolic changes in type 2 DM metabolic abnormalities of type 2 DM are the results of insulin resistance (in liver, muscle & adipose tissue) 1- hyperglycemia (BUT: ketosis is minimal or absent) 2- hypertriacylglyceridemia

Metabolic changes in type 2 DM Hyperglycemia in type 2 DM Causes: as a result of insulin resistance 1- increased gluconeogenesis (glucose production) by liver 2- diminished peripheral use of glucose _______________________________________________ Ketosis: usually minimal or absent because of the presence of insulin (even with resistance) is sufficient to prevent liver ketogenesis

Metabolic changes in type 2 DM Hypertriacylglyceridemia in type 2 DM insulin resistance (in adipose tissues) active hormone sensitive lipase Lipolysis free fatty acids in liver VLDL synthesis in liver hypertriacylglyceridemia

Treatment of type 2 DM AIM: 1- to maintain blood glucose concentrations within normal limits 2- to prevent the development of long-term complications occurring due to prolonged hyperglycemia Lines of treatment: 1- weight reduction (to control insulin resistance) 2- exercise 3- dietary modification 4- hypoglycemic agents 5- insulin (required in some cases)

Chronic effects of DM The long-standing elevation of blood glucose (hyperglycemia) causes the chronic complications of DM some complications of DM for long durations: 1- Atherosclerosis : retinopathy nephropathy neuropathy cardiovascular diseases & stroke 2- Sorbitol accumulation in certain cells complications 3- Glycated proteins formation---- microvascular complications

Chronic effects of DM (cont.) in cells where entry of glucose is not dependent on insulin (eye lens, retina, kidney, neurones) intracelluar levels of glucose SORBITOL Cataract diabetic retinopathy diabetic nephropathy diabetic neuropathy

Chronic effects of DM (cont.) Cellular glycated proteins formation: Hyperglycemia promotes condensation of glucose with many cellular proteins Glycated prioteins mediate some early microvacular changes of DM

Prevention of DM For prevention of DM occurrence 1- type 1: no preventive measures available 2- type 2: combined regimen of medical nutritional therapy & exercise For prevention of occurrence complications type 1 DM: tight control of may prevent complications (may prevent complications in DM type 2 also)